Cite
MLA Citation
X. Mariette et al.. “THU0163 Early Response as A Predictor of Long-Term Clinical Response in DMARD-Naïve Patients with Severe, Active and Progressive RA Treated with Certolizumab Pegol plus Optimized MTX versus Optimized MTX Alone.” Annals of the rheumatic diseases, vol. 75, n.d., p. 242. http://access.bl.uk/ark:/81055/vdc_100135161473.0x000052